文献
J-GLOBAL ID:202202266458814621
整理番号:22A0769064
NTRK1融合は9つの癌型を通して非侵襲的血漿次世代シークエンシング(NGS)により同定される【JST・京大機械翻訳】
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
著者 (26件):
Rolfo Christian
(Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai System & Icahn School of Medicine, Mount Sinai, New York, NY, USA)
,
Drilon Alexander
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Hong David
(Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA)
,
McCoach Caroline
(University of California, San Francisco, CA, USA)
,
McCoach Caroline
(Genentech, South San Francisco, CA, USA)
,
Dowlati Afshin
(University Hospitals Cleveland Medical Center, Cleveland, OH, USA)
,
Lin Jessica J.
(Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA)
,
Russo Alessandro
(Thoracic Oncology & Experimental Therapeutics Program, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA)
,
Schram Alison M.
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Liu Stephen V.
(Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
,
Nieva Jorge J.
(Keck School of Medicine of USC, Section Head - Solid Tumors, USC/Norris Cancer Center, Los Angeles, CA, USA)
,
Nguyen Timmy
(University Hospitals Cleveland Medical Center, Cleveland, OH, USA)
,
Eshaghian Shahrooz
(James R. Berenson, MD, Inc., West Hollywood, CA, USA)
,
Morse Michael
(Duke Cancer Institute, Division of Medical Oncology, Durham, NC, USA)
,
Gettinger Scott
(Yale Comprehensive Cancer Center, New Haven, CT, USA)
,
Mobayed Mohammad
(ProMedica Bay Park Hospital Cancer, Sylvania, OH, USA)
,
Goldberg Sarah
(Yale Comprehensive Cancer Center, New Haven, CT, USA)
,
Araujo-Mino Emilio
(Kymera Cancer Center and University of New Mexico, Roswell, NM, USA)
,
Vidula Neelima
(Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA)
,
Bardia Aditya
(Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA)
,
Subramanian Janakiraman
(Saint Lukes Cancer Institute/University of Missouri, Kansas City, MO, USA)
,
Sashital Deepa
(US Oncology Network, Texas Oncology, Baytown, TX, USA)
,
Stinchcombe Thomas
(Duke Cancer Institute, Division of Medical Oncology, Durham, NC, USA)
,
Kiedrowski Lesli
(Guardant Health, Redwood City, CA, USA)
,
Price Kristin
(Guardant Health, Redwood City, CA, USA)
,
Gandara David R.
(UC Davis Comprehensive Cancer Center, Sacramento, CA, USA)
資料名:
British Journal of Cancer
(British Journal of Cancer)
巻:
126
号:
3
ページ:
514-520
発行年:
2022年
JST資料番号:
C0922B
ISSN:
0007-0920
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)